EQ Long Call Strategy
EQ (Equillium, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which is in Phase III clinical trials for the treatment of acute graft-versus-host disease; completed Phase Ib clinical trial for the treatment of asthma disease; and Phase Ib clinical trial for the treatment of and lupus nephritis. It also develops EQ101 for treatment of cutaneous T cell lymphoma and alopecia areata; and EQ102 to treat various gastrointestinal diseases. The company was formerly known as Attenuate Biopharmaceuticals, Inc. and changed its name to Equillium, Inc. in May 2017. Equillium, Inc. was incorporated in 2017 and is headquartered in La Jolla, California.
EQ (Equillium, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $82.1M, a beta of 1.67 versus the broader market, a 52-week range of 0.27-2.7, average daily share volume of 429K, a public-listing history dating back to 2018, approximately 35 full-time employees. These structural characteristics shape how EQ stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.67 indicates EQ has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a long call on EQ?
A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.
Current EQ snapshot
As of May 15, 2026, spot at $2.21, ATM IV 116.70%, IV rank 20.28%, expected move 33.46%. The long call on EQ below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this long call structure on EQ specifically: EQ IV at 116.70% is on the cheap side of its 1-year range, which favors premium-buying structures like a EQ long call, with a market-implied 1-standard-deviation move of approximately 33.46% (roughly $0.74 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated EQ expiries trade a higher absolute premium for lower per-day decay. Position sizing on EQ should anchor to the underlying notional of $2.21 per share and to the trader's directional view on EQ stock.
EQ long call setup
The EQ long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With EQ near $2.21, the first option leg uses a $2.21 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed EQ chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 EQ shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $2.21 | N/A |
EQ long call risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.
EQ long call payoff curve
Modeled P&L at expiration across a range of underlying prices for the long call on EQ. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use long call on EQ
Long calls on EQ express a bullish thesis with defined risk; traders use them ahead of EQ catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
EQ thesis for this long call
The market-implied 1-standard-deviation range for EQ extends from approximately $1.47 on the downside to $2.95 on the upside. A EQ long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current EQ IV rank near 20.28% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on EQ at 116.70%. As a Healthcare name, EQ options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to EQ-specific events.
EQ long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. EQ positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move EQ alongside the broader basket even when EQ-specific fundamentals are unchanged. Long-premium structures like a long call on EQ are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current EQ chain quotes before placing a trade.
Frequently asked questions
- What is a long call on EQ?
- A long call on EQ is the long call strategy applied to EQ (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With EQ stock trading near $2.21, the strikes shown on this page are snapped to the nearest listed EQ chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are EQ long call max profit and max loss calculated?
- Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the EQ long call priced from the end-of-day chain at a 30-day expiry (ATM IV 116.70%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a EQ long call?
- The breakeven for the EQ long call priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current EQ market-implied 1-standard-deviation expected move is approximately 33.46%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long call on EQ?
- Long calls on EQ express a bullish thesis with defined risk; traders use them ahead of EQ catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
- How does current EQ implied volatility affect this long call?
- EQ ATM IV is at 116.70% with IV rank near 20.28%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.